Skip to main content

Table 3 VAS pain results for Neuragen PN® and the placebo where SE stands for standard error of the mean.

From: The effect of Neuragen PN® on Neuropathic pain: A randomized, double blind, placebo controlled clinical trial

Treatment

Time

Mean

SE

Neuragen PN®

Pre

4.7

0.2

Placebo

Pre

4.2

0.2

Neuragen PN®

Post

2.53

0.2

Placebo

Post

3.98

0.2

  1. There was an overall pain reduction for both treatments from pre to post application. Further, Neuragen PN® had significantly greater pain reduction effects than the placebo (p < .05)
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us